13F-HR filed by UNIVERSITY OF CHICAGO
UNIVERSITY OF CHICAGO filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-07-15, with 7 holding rows worth $129,724,401.
- Accession
- 0001104659-24-079734
- Filer
- CIK 314957
- Filed
- 2024-07-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 7 entries on the cover page, a total value of $129,724,401 stated on the cover page (in dollars after the unit check, H1), rows summing to $129,724,401 with VALUE read as dollars as filed, 13F file number 028-00018. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Vanguard Total Bond Market ETF | 921937835 | SHS | 766,763 | $55,245,274 | dollars as filed | |
| Vanguard Total World Stock ETF | 922042742 | SHS | 335,471 | $37,784,099 | dollars as filed | |
| Vanguard S&P 500 ETF | 922908363 | COM | 68,413 | $34,337,408 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 6,000 | $1,029,120 | dollars as filed | |
| NKGen Biotech Inc | 65488A101 | Equity | 550,000 | $698,500 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 10,000 | $468,700 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 48,731 | $161,300 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-24-079734 | this filing | 2024-07-15 | acceptance time not in the bulk data set |